Nephros, Inc. (NASDAQ:NEPH) Sees Significant Decrease in Short Interest

Nephros, Inc. (NASDAQ:NEPH) saw a significant drop in short interest in September. As of September 30th, there was short interest totalling 2,600 shares, a drop of 25.7% from the September 15th total of 3,500 shares. Based on an average daily trading volume, of 14,300 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are sold short.

Nephros Trading Up 2.7 %

NASDAQ NEPH opened at $1.50 on Tuesday. The firm has a market cap of $15.82 million, a price-to-earnings ratio of -10.71 and a beta of 1.18. The company has a 50 day moving average of $1.80 and a 200-day moving average of $2.03. Nephros has a 1-year low of $1.43 and a 1-year high of $4.04.

Nephros (NASDAQ:NEPH) last posted its quarterly earnings data on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02). The firm had revenue of $3.25 million for the quarter. Nephros had a negative return on equity of 15.64% and a negative net margin of 9.40%.

Institutional Trading of Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new stake in Nephros, Inc. (NASDAQ:NEPH) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned approximately 0.17% of Nephros at the end of the most recent reporting period. 41.10% of the stock is currently owned by institutional investors and hedge funds.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.